These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 35976169

  • 1. miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy.
    Akpınar K, Aslan D, Fenkçi SM, Caner V.
    Diagnosis (Berl); 2022 Nov 01; 9(4):499-507. PubMed ID: 35976169
    [Abstract] [Full Text] [Related]

  • 2. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R.
    PLoS One; 2016 Nov 01; 11(3):e0150154. PubMed ID: 26930277
    [Abstract] [Full Text] [Related]

  • 3. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
    Chien HY, Chen CY, Chiu YH, Lin YC, Li WC.
    Int J Med Sci; 2016 Nov 01; 13(6):457-65. PubMed ID: 27279796
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy.
    Li W, Yang S, Qiao R, Zhang J.
    Clin Lab; 2018 May 01; 64(5):709-718. PubMed ID: 29739042
    [Abstract] [Full Text] [Related]

  • 7. Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy.
    Abdel-Tawab MS, Mohamed MG, Doudar NA, Rateb EE, Reyad HR, Elazeem NAA.
    Mol Biol Rep; 2023 Dec 01; 50(12):9793-9803. PubMed ID: 37831346
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of hsa-miR-100-5p May Be a Protective Factor in the Early Stages of Nephropathy in Type 1 Diabetes Mellitus.
    Pinheiro AHG, Pereira BO, Silva LSD, Melo FTC, Souza ACCB, Leal VSG, Figueiredo PBB, Neto JFA, Santos MCD, Queiroz NNM, Felício KM, Ribeiro-Dos-Santos Â, Felício JS, Cavalcante GC.
    Int J Mol Sci; 2024 May 23; 25(11):. PubMed ID: 38891851
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy.
    Kim H, Bae YU, Jeon JS, Noh H, Park HK, Byun DW, Han DC, Ryu S, Kwon SH.
    J Transl Med; 2019 Jul 22; 17(1):236. PubMed ID: 31331349
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease.
    Mishra DD, Sahoo B, Maurya PK, Sharma R, Varughese S, Prasad N, Tiwari S.
    Front Endocrinol (Lausanne); 2023 Jul 22; 14():1157194. PubMed ID: 37251672
    [Abstract] [Full Text] [Related]

  • 13. Circulating miRNAs in Type 2 Diabetic Patients with and without Albuminuria in Malaysia.
    Zahari Sham SY, Ng CT, Azwar S, Yip WK, Abdullah M, Thevandran K, Osman M, Seow HF.
    Kidney Blood Press Res; 2022 Jul 22; 47(2):81-93. PubMed ID: 35158353
    [Abstract] [Full Text] [Related]

  • 14. microRNA-29b-3p attenuates diabetic nephropathy in mice by modifying EZH2.
    Zhao Y, Li D, Zhou P, Zhao Y, Kuang J.
    Hormones (Athens); 2023 Jun 22; 22(2):223-233. PubMed ID: 36692688
    [Abstract] [Full Text] [Related]

  • 15. New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203.
    Eroglu İ, Korkmaz H, Ozturk KH, Sirin FB, Sevik S, Afsar B.
    Minerva Endocrinol (Torino); 2022 Sep 22; 47(3):314-324. PubMed ID: 33331738
    [Abstract] [Full Text] [Related]

  • 16. Metformin mediates MicroRNA-21 regulated circulating matrix metalloproteinase-9 in diabetic nephropathy: an in-silico and clinical study.
    Khokhar M, Roy D, Bajpai NK, Bohra GK, Yadav D, Sharma P, Purohit P.
    Arch Physiol Biochem; 2023 Dec 22; 129(6):1200-1210. PubMed ID: 34087084
    [Abstract] [Full Text] [Related]

  • 17. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
    Liu Q, Wang M, Xu T, Liang W, Yang F.
    J Clin Lab Anal; 2022 Feb 22; 36(2):e24210. PubMed ID: 34964177
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A, Liu G, Zhong X, Hu S, Ma R, Gou L, Zafar MI, Chen L.
    Med Sci Monit; 2019 Mar 05; 25():1699-1708. PubMed ID: 30835718
    [Abstract] [Full Text] [Related]

  • 19. Plasma levels of hsa-miR-152-3p are associated with diabetic nephropathy in patients with type 2 diabetes.
    Roux M, Perret C, Feigerlova E, Mohand Oumoussa B, Saulnier PJ, Proust C, Trégouët DA, Hadjadj S.
    Nephrol Dial Transplant; 2018 Dec 01; 33(12):2201-2207. PubMed ID: 29361146
    [Abstract] [Full Text] [Related]

  • 20. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1.
    Meng L, Li G, Liu X, Jiang J, Zhu M, Sun Y.
    Clin Lab; 2018 Jul 01; 64(7):1177-1182. PubMed ID: 30146830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.